Member News

Event honors Gary Felsenfeld

Thoru Pederson Bruce Alberts
By Thoru Pederson and Bruce Alberts
Feb. 12, 2024

A celebration honoring Gary Felsenfeld, a pioneer in the study of nucleic acid structure and chromatin, brought together more than 25 of his former National Institutes of Health lab members recently to offer reminiscences. Inspired by our decades-long admiration of Felsenfeld, the authors organized this event in Washington, D.C.

Group photo of event celebrating Gary Felsenfeld.
Daniel Felsenfeld
Longtime NIH researcher Gary Felsenfeld, center, is surrounded by former lab members and admirers during a celebration in January at the Cosmos Club in Washington, D.C.

Felsenfeld’s career spanned three eras of biophysical chemistry and molecular biology.  He was the first, with David Davies and Alex Rich, to demonstrate the existence of three-stranded RNA and (independently with Stuart Orkin) identified GATA1, an early discovery of an erythroid gene regulatory factor.   In the 1970s, he made a major discovery on the structure of chromatin and later defined key regulatory elements of gene expression, including “insulator” elements and the transcription factor CTCF. 

A member of the American Society for Biochemistry and Molecular Biology for more than 60 years who served on the Journal of Biological Chemistry editorial board in the 1960s, Felsenfeld has received many honors in his career but this was a very personal one, as we intended and as he described it afterwards. 

During the evening, Felsenfeld shared memories of some of his mentors, including protein scientist John Edsall at Harvard, where Felsenfeld was an undergraduate, and two-time Nobel Prize winner, biochemist and peace activist Linus Pauling at the California Institute of Technology, where Felsenfeld earned his Ph.D. — an enriching historical connection for most of the guests who knew these scientists by name only. 

Felsenfeld, soon to be 95, spent almost his entire career at the National Institutes of Health, where he served as the Molecular Biology Section chief in the National Institute of Diabetes and Digestive and Kidney Diseases and is now an NIH distinguished investigator and scientist emeritus.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Thoru Pederson
Thoru Pederson

Thoru Pederson is a professor of biochemistry and molecular biotechnology at the University of Massachusetts Chan Medical School.

Bruce Alberts
Bruce Alberts

Bruce Alberts is a professor of biochemistry and biophysics, University of California San Francisco.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Introducing STEM before self-doubt
Profile

Introducing STEM before self-doubt

March 26, 2026

With hair biology workshops and hands-on STEM programs, Shyretha Brown is building pathways for young girls to see themselves in science. Through Building Bridges, she blends education, identity and access to expand who feels welcome in STEM.

In memoriam: Richard Wolfenden
In Memoriam

In memoriam: Richard Wolfenden

March 23, 2026

He was an enzymologist whose work helped spur the development of ACE inhibitor drugs and has been an ASBMB member since 1967.

Tansey named department chair
Member News

Tansey named department chair

March 16, 2026

He has been a faculty member at Otterbein University since 2002.

In memoriam: Joel Habener
In Memoriam

In memoriam: Joel Habener

March 16, 2026

He discovered GLP-1, which helped pave the way for transformative diabetes and obesity therapies, and he was an ASBMB member for 25 years.

In memoriam: Walter A. Shaw
In Memoriam

In memoriam: Walter A. Shaw

March 9, 2026

He is the namesake for the Walter A. Shaw Young Investigator Award in Lipid Research and founded Avanti Polar Lipids.

Dorn named assistant professor
Member News

Dorn named assistant professor

March 9, 2026

She will open her lab at the University of Vermont in fall 2026, and her research will focus on catalysis, synthetic methodology and medicinal chemistry.